- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Omega Therapeutics is a biotechnology business based in the US. Omega Therapeutics shares (OMGA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.39 – the same closing value as a week prior. Omega Therapeutics employs 93 staff and has a trailing 12-month revenue of around $6.3 million.
Our top picks for where to buy Omega Therapeutics stock
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Omega Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – OMGA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Omega Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Omega Therapeutics stock price (NASDAQ: OMGA)
Use our graph to track the performance of OMGA stocks over time.Omega Therapeutics shares at a glance
Information last updated 2024-10-25.
| Latest market close | $1.39 |
|---|---|
| 52-week range | $0.89 - $6.30 |
| 50-day moving average | $1.28 |
| 200-day moving average | $2.40 |
| Wall St. target price | $11.14 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-1.42 |
Is it a good time to buy Omega Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Omega Therapeutics price performance over time
Historical closes compared with the close of $1.39 from 2024-10-25
| 1 week (2024-10-22) | 1.39 |
|---|---|
| 1 month (2024-09-27) | 5.30% |
| 3 months (2024-07-29) | -26.46% |
| 6 months (2024-04-29) | -39.30% |
| 1 year (2023-10-27) | -14.20% |
|---|---|
| 2 years (2022-10-28) | -72.03% |
| 3 years (2021-10-29) | 29.38 |
| 5 years (2019-10-25) | N/A |
Omega Therapeutics financials
| Revenue TTM | $6.3 million |
|---|---|
| Gross profit TTM | $-74,023,000 |
| Return on assets TTM | -25.37% |
| Return on equity TTM | -129.15% |
| Profit margin | 0% |
| Book value | $0.48 |
| Market Capitalization | $80 million |
TTM: trailing 12 months
Omega Therapeutics share dividends
We're not expecting Omega Therapeutics to pay a dividend over the next 12 months.
You may also wish to consider:
- Qiagen (QGEN.US) (2.94% forward annual dividend yield)
Omega Therapeutics share price volatility
Over the last 12 months, Omega Therapeutics's shares have ranged in value from as little as $0.89 up to $6.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Omega Therapeutics's is 1.841. This would suggest that Omega Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Omega Therapeutics's beta into context you can compare it against those of similar companies.
- Qiagen (QGEN.US): 0.388
- Pacific Biosciences of California (PACB.US): 2.045
- Illumina (ILMN.US): 1.147
Omega Therapeutics overview
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Frequently asked questions
What percentage of Omega Therapeutics is owned by insiders or institutions?Currently 1.622% of Omega Therapeutics shares are held by insiders and 94.104% by institutions. How many people work for Omega Therapeutics?
Latest data suggests 93 work at Omega Therapeutics. When does the fiscal year end for Omega Therapeutics?
Omega Therapeutics's fiscal year ends in December. Where is Omega Therapeutics based?
Omega Therapeutics's address is: 20 Acorn Park Drive, Cambridge, MA, United States, 02140 What is Omega Therapeutics's ISIN number?
Omega Therapeutics's international securities identification number is: US68217N1054
More resources on Finder
More guides on Finder
-
How to buy Zentek stock (ZTEK)
Steps to owning and managing ZTEK, with 24-hour and historical pricing before you buy.
-
How to buy ATAI Life Sciences stock (Atai Life Sciences)
Steps to owning and managing ATAI, with 24-hour and historical pricing before you buy.
-
How to buy Seelos Therapeutics stock (SEEL)
Steps to owning and managing SEEL, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Humana stock (HUM)
Steps to owning and managing HUM, with 24-hour and historical pricing before you buy.
-
How to buy Illumina stock (ILMN)
Steps to owning and managing ILMN, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Moderna stock (MRNA)
Steps to owning and managing MRNA, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question